SCHEMBL7140604

SCHEMBL7140604

CC(C)(C)OC(=O)Nc1cc(OC(C)(C)C)c(-c2ccc(F)cc2)cc1[N+](=O)[O-]

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 3/20 0.38
ABCC1 P33527 3/20 0.38
KCNQ4 P56696 1/20 0.38
KCNQ5 Q9NR82 1/20 0.38
MMP8 P22894 5/20 0.37
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37
MMP13 P45452 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
CYP17A1 P05093 1/20 0.37
MMP3 P08254 2/20 0.36
GRM2 Q14416 1/20 0.36
AR P10275 2/20 0.35
KCNMA1 Q12791 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7138373 0.92 ABCB1 (0.47) ABCB1ABCC1MMP8MMP1MMP2
SCHEMBL7138025 0.88 KCNQ4 (0.38) ABCB1ABCC1KCNQ4KCNQ5MMP8
SCHEMBL7143138 0.88 MEN1 (0.37) ABCB1ABCC1KCNQ4KCNQ5MMP8
SCHEMBL7139923 0.87 ALDH1A1 (0.40) ABCB1ABCC1KCNQ4KCNQ5ALDH1A1
SCHEMBL7143992 0.87 MAPT (0.40) ABCB1ABCC1KCNQ4KCNQ5MMP8
SCHEMBL7145942 0.86 KCNQ4 (0.36) ABCB1ABCC1KCNQ4KCNQ5MMP8
SCHEMBL7146551 0.86 ABCB1 (0.39) ABCB1ABCC1KCNQ4KCNQ5MMP8
SCHEMBL7142774 0.85 KCNQ4 (0.38) ABCB1ABCC1KCNQ4KCNQ5MMP8
SCHEMBL7138538 0.84 RAB9A (0.41) MMP8MMP1MMP2MMP9MMP13
SCHEMBL7145392 0.82 HDAC2 (0.44) KCNQ4KCNQ5CYP17A1GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed